BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 20681684)

  • 1. Anticancer drug release from a mesoporous silica based nanophotocage regulated by either a one- or two-photon process.
    Lin Q; Huang Q; Li C; Bao C; Liu Z; Li F; Zhu L
    J Am Chem Soc; 2010 Aug; 132(31):10645-7. PubMed ID: 20681684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous silica nanoparticle-based double drug delivery system for glucose-responsive controlled release of insulin and cyclic AMP.
    Zhao Y; Trewyn BG; Slowing II; Lin VS
    J Am Chem Soc; 2009 Jun; 131(24):8398-400. PubMed ID: 19476380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles.
    Thomas CR; Ferris DP; Lee JH; Choi E; Cho MH; Kim ES; Stoddart JF; Shin JS; Cheon J; Zink JI
    J Am Chem Soc; 2010 Aug; 132(31):10623-5. PubMed ID: 20681678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.
    Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC
    Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere.
    Vivero-Escoto JL; Slowing II; Wu CW; Lin VS
    J Am Chem Soc; 2009 Mar; 131(10):3462-3. PubMed ID: 19275256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
    Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.
    Guo R; Li LL; Zhao WH; Chen YX; Wang XZ; Fang CJ; Feng W; Zhang TL; Ma X; Lu M; Peng SQ; Yan CH
    Nanoscale; 2012 Jun; 4(11):3577-83. PubMed ID: 22543578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photocontrolled nuclear-targeted drug delivery by single component photoresponsive fluorescent organic nanoparticles of acridin-9-methanol.
    Jana A; Saha B; Banerjee DR; Ghosh SK; Nguyen KT; Ma X; Qu Q; Zhao Y; Singh ND
    Bioconjug Chem; 2013 Nov; 24(11):1828-39. PubMed ID: 24195782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminescent carbon dot-gated nanovehicles for pH-triggered intracellular controlled release and imaging.
    Zhou L; Li Z; Liu Z; Ren J; Qu X
    Langmuir; 2013 May; 29(21):6396-403. PubMed ID: 23642102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light- and pH-responsive release of doxorubicin from a mesoporous silica-based nanocarrier.
    Knežević NŽ; Trewyn BG; Lin VS
    Chemistry; 2011 Mar; 17(12):3338-42. PubMed ID: 21337435
    [No Abstract]   [Full Text] [Related]  

  • 14. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release.
    Niu N; He F; Ma P; Gai S; Yang G; Qu F; Wang Y; Xu J; Yang P
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3250-62. PubMed ID: 24521281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery.
    Chen Y; Chen H; Zeng D; Tian Y; Chen F; Feng J; Shi J
    ACS Nano; 2010 Oct; 4(10):6001-13. PubMed ID: 20815402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery.
    He H; Xiao H; Kuang H; Xie Z; Chen X; Jing X; Huang Y
    Colloids Surf B Biointerfaces; 2014 May; 117():75-81. PubMed ID: 24632033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
    Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
    J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luciferase and luciferin co-immobilized mesoporous silica nanoparticle materials for intracellular biocatalysis.
    Sun X; Zhao Y; Lin VS; Slowing II; Trewyn BG
    J Am Chem Soc; 2011 Nov; 133(46):18554-7. PubMed ID: 22007786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
    Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
    Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
    Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.